GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » COGS-to-Revenue

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) COGS-to-Revenue : 0.34 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co COGS-to-Revenue?

Hunan Jingfeng Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥33.8 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥100.6 Mil.

Hunan Jingfeng Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hunan Jingfeng Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 66.35%.

Hunan Jingfeng Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co COGS-to-Revenue Chart

Hunan Jingfeng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.36 0.38 0.24 0.28

Hunan Jingfeng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.22 0.29 0.49 0.34

Hunan Jingfeng Pharmaceutical Co COGS-to-Revenue Calculation

Hunan Jingfeng Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=185.519 / 656.894
=0.28

Hunan Jingfeng Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=33.843 / 100.576
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Jingfeng Pharmaceutical Co  (SZSE:000908) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hunan Jingfeng Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 33.843 / 100.576
=66.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hunan Jingfeng Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:000952 SHSE:600671 SZSE:000705 SZSE:001367 SZSE:301281 SZSE:300006 SHSE:600613 SZSE:002198 SHSE:600666 SZSE:301507 LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN
Traded in Other Exchanges
N/A
Address
500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN
Website
http://www.jfyiyao.com
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
Executives
Zhou Shen Dong Supervisors
Ye Xiang Wu Directors, executives
Ma Xian Peng Executives
Cong Shu Fen Executives
Zhang Jun Guo Executives
Jian Wei Guang Directors, executives
Bi Yuan Secretary, Director
Ou Yang Yan Li Secretary, Director
Luo Li Director
Luo Bin Director
Li Tong Directors, executives
Wei Ze Chun Director
Tang Zhi Executives
Ou Yang Chun Bao Executives
Mao Hui Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines